# The Effect of Cetirizine on Bronchoconstriction

> **NCT03340740** · PHASE4 · COMPLETED · sponsor: **New York City Health and Hospitals Corporation** · enrollment: 40 (actual)

## Conditions studied

- Allergic Rhinitis
- Asthma

## Interventions

- **DRUG:** Cetirizine Hydrochloride 1 MG/ML
- **DRUG:** Placebo - Concentrate

## Key facts

- **NCT ID:** NCT03340740
- **Lead sponsor:** New York City Health and Hospitals Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-11
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03340740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03340740, "The Effect of Cetirizine on Bronchoconstriction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03340740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*